Bioactive Milk Peptides and Blood Pressure

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2009 by Valio Ltd.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Helsinki University
Information provided by:
Valio Ltd
ClinicalTrials.gov Identifier:
NCT01031485
First received: December 11, 2009
Last updated: NA
Last verified: December 2009
History: No changes posted
  Purpose

The purpose of this study is to investigate the effects of bioactive milk peptides on blood pressure in mildly hypertensive subjects.


Condition Intervention Phase
Stage 1 Hypertension
Dietary Supplement: Milk peptides and plant sterols
Other: Placebo
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind

Resource links provided by NLM:


Further study details as provided by Valio Ltd:

Primary Outcome Measures:
  • Blood pressure

Arms Assigned Interventions
Active Comparator: Spread with milk peptides and plant sterols Dietary Supplement: Milk peptides and plant sterols
Placebo Comparator: Standard spread Other: Placebo

  Eligibility

Ages Eligible for Study:   30 Years to 60 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • age 30-60 years
  • systolic blood pressure 140-160 mmHg and diastolic blood pressure 90-99 mmHg in office measurement
  • apparently healthy

Exclusion Criteria:

  • antihypertensive and lipid-lowering drugs
  • unstable coronary artery disease, diabetes, malignant diseases, secondary hypertension
  • BMI > 32 kg/m2
  • milk allergy
  • smoking
  • alcohol abuse
  • pregnancy, lactation
  • simultaneous participation in other clinical trial
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01031485

Locations
Finland
Valio Ltd
Helsinki, Uusimaa, Finland, 00370
Sponsors and Collaborators
Valio Ltd
Helsinki University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01031485     History of Changes
Other Study ID Numbers: Valio-70
Study First Received: December 11, 2009
Last Updated: December 11, 2009
Health Authority: Finland: Ethics Committee

Keywords provided by Valio Ltd:
hypertension
blood pressure
milk peptides
bioactive peptides
randomized controlled trial

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on October 19, 2014